ArticleFrontiers in immunology2026
Identification of the immunoprotective activity of Mori Cortex Radicis ethanol extract against aquaculture pathogens (
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Mori Cortex Radicis (MCR) is an important Chinese herbal medicine with antitussive, anti-inflammatory, and analgesic effects. It is abundant in resources and low in cost, but its application in the control of fish pathogens has been insufficiently studied. Methods: We employed an ethanol extraction method to obtain the MCR ethanol extract (MCR-EE), and analyzed its small-molecule and macromolecular components using LC-MS and commercial kits, respectively. Subsequently, using a crucian carp ( Results: The MCR-EE was prepared. The contents of proteins, polysaccharides, and polyphenols of MCR-EE were 0.7%, 0.44%, and 1.21%, respectively. A total of 646 small substances were identified in MCR-EE, and the five most abundant small-molecule compounds were L(+)-Arginine, 1-Deoxynojirimycin, 9,12,13-Todea, 4-Guanidinobutanoic acid, and Kelampayoside A. The MCR-EE enhanced the general phagocytic activity of fish blood leukocytes and the activity of immune factors. The immune protection rates of MCR-EE against Conclusion: MCR-EE exhibits immunomodulatory activity and holds promise as an immunostimulant for the prevention and control of fish pathogens (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.